Cargando…

Combination of venlafaxine and phentermine/topiramate induced psychosis: A case report

BACKGROUND: Various publications have noted increases in dopamine, specifically in the mesolimbic region of the brain, to have a direct correlation to psychotic-like symptoms. Venlafaxine, a first-line medication for depression, inhibits the reuptake of both serotonin and norepinephrine. Additionall...

Descripción completa

Detalles Bibliográficos
Autores principales:	Homola, Jaclyn, Hieber, Robin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	College of Psychiatric & Neurologic Pharmacists 2018
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6007738/ https://www.ncbi.nlm.nih.gov/pubmed/29955552 http://dx.doi.org/10.9740/mhc.2018.03.095

Ejemplares similares

Phentermine-topiramate: First combination drug for obesity
por: Singh, Jagjit, et al.
Publicado: (2015)

Phentermine and topiramate for the management of obesity: a review
por: Cosentino, Gina, et al.
Publicado: (2011)

Clinical utility of phentermine/topiramate (Qsymia™) combination for the treatment of obesity
por: Shin, Jin Hee, et al.
Publicado: (2013)

Phentermine–topiramate extended release for the dual treatment of obesity and sleep-related eating disorder: a case report
por: Grunvald, Eduardo, et al.
Publicado: (2022)

Cardiovascular Safety During and After Use of Phentermine and Topiramate
por: Ritchey, Mary E, et al.
Publicado: (2018)

Cardiovascular effects of phentermine and topiramate: a new drug combination for the treatment of obesity
por: Jordan, Jens, et al.
Publicado: (2014)

A Narrative Review: Phentermine and Topiramate for the Treatment of Pediatric Obesity
por: Kim, Anthony, et al.
Publicado: (2023)

Recurrent Psychosis after Phentermine Administration in a Young Female: A Case Report
por: Jo, Hyun-Sic, et al.
Publicado: (2019)

Management of obesity and cardiometabolic risk – role of phentermine/extended release topiramate
por: Sweeting, Arianne N, et al.
Publicado: (2014)

Case report of PLXNA4 variant associated with hyper-response to phentermine/topiramate pharmacotherapy: Potential genetic basis for superior weight loss response?
por: Paszkowiak, Maria, et al.
Publicado: (2023)

Topiramate-induced psychosis in two members of the one family: a case report
por: José, Ricardo Jorge Paixão, et al.
Publicado: (2008)

Formulary Management of 2 New Agents: Lorcaserin and Phentermine/Topiramate for Weight Loss
por: Kelly, Elizabeth M., et al.
Publicado: (2013)

Controlled-Release Phentermine/Topiramate in Severely Obese Adults: A Randomized Controlled Trial (EQUIP)
por: Allison, David B., et al.
Publicado: (2012)

A case of phentermine-induced psychosis: the need for caution for drug-drug interactions
por: Sreevalsam Anil, S., et al.
Publicado: (2023)

VENLAFAXINE INDUCED HYPERTENSION:A CASE REPORT
por: Pardal, P.K., et al.
Publicado: (2001)

Prevention of Type 2 Diabetes in Subjects With Prediabetes and Metabolic Syndrome Treated With Phentermine and Topiramate Extended Release
por: Garvey, W. Timothy, et al.
Publicado: (2014)

Pulmonary Hypertension Associated with Use of Phentermine
por: Bang, Woo-Dae, et al.
Publicado: (2010)

VENLAFAXINE-INDUCED MANIA
por: Jagadheesan, K., et al.
Publicado: (2001)

Kleptomania Induced by Venlafaxine
por: Sakurada, Kumi, et al.
Publicado: (2021)

Topiramate: Liver injury: case report
Publicado: (2021)

Topiramate induced acute transient myopia: a case report
por: Gawley, Sandra D
Publicado: (2009)

Topiramate-induced acute onset myopia: a case report
por: Medagama, Arjuna, et al.
Publicado: (2014)

Topiramate-Induced Acute Psychotic Symptoms: A Case Report
por: Jafarpour, Hamed, et al.
Publicado: (2020)

Venlafaxine-induced psychotic symptoms
por: Safeekh, A. T., et al.
Publicado: (2009)

A Case of Venlafaxine-Induced Interstitial Lung Disease
por: Oh, Serim, et al.
Publicado: (2014)

A case of venlafaxine-induced angioedema in an older adult
por: Griffin, Hailee, et al.
Publicado: (2021)

Presumed topiramate retinopathy: a case report
por: Yeung, Tiffany L. M., et al.
Publicado: (2016)

Topiramate-induced severe heatstroke in an adult patient: a case report
por: Canel, Lucie, et al.
Publicado: (2016)

Topiramate induced peripheral neuropathy: A case report and review of literature
por: Hamed, Sherifa Ahmed
Publicado: (2017)

Topiramate-Induced Acute Myopia, Diplopia, and Photosensitivity: A Case Report
por: Kocamaz, Murat, et al.
Publicado: (2019)

Levetiracetam/topiramate: Drug ineffective: case report
Publicado: (2022)

Venlafaxine-induced encephalopathy in term newborn
por: Maalouli, Walid M, et al.
Publicado: (2020)

Phentermine and topiramate extended-release: a new treatment for obesity and its role in a complications-centric approach to obesity medical management
por: Garvey, William Timothy
Publicado: (2013)

Topiramate-induced angle closure glaucoma: Two unique case reports
por: Alzendi, Nouf A., et al.
Publicado: (2021)

Bradycardia caused by interaction of venlafaxine and cyclosporine: A case report
por: Azizi, Marzieh, et al.
Publicado: (2019)

A Rare Case of Phentermine-Induced Nonischemic Cardiomyopathy
por: Damani, Devanshi, et al.
Publicado: (2022)

4-Year Cost Trajectories in Real-World Patients Matched to the Metabolic Profiles of Trial Subjects Before/After Treatment with Phentermine-Topiramate
por: Li, James, et al.
Publicado: (2015)

Apathy symptoms induced by low‐dose venlafaxine: Two cases
por: Sato, Shinji, et al.
Publicado: (2020)

Topiramate in the treatment of compulsive sexual behavior: case report
por: Khazaal, Yasser, et al.
Publicado: (2006)

Ocular adverse effects of Topiramate: Two case reports
por: Mandal, Ananya, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_1n09r1a5co2td4f380hmiiubjn